The Falsified Medicines Directive (FMD) incorporates a number of initiatives to safeguard the pharmaceutical supply chain in Europe. Read the latest update here.
We will be exhibiting at the National Manufacturing and Supply Chain Conference & Exhibition in Citywest Hotel on January 26th.
The AIS November newsletter has just been published. This month's publication covers the AIS service and spare parts division. Our fully trained and equipped on-site Service Engineers are on hand to deal with any issues that may arise.
The AIS October newsletter has just been published. This month's publication covers our extensive Datalogic barcode scanner range covering fixed position scanning, general purpose handheld scanners, industrial handheld scanners and mobile barcode scanners.
Datalogic today announced the launch of IMPACT+OCR, the smartest solution for variable data printing inspection in the Food & Beverage industry.
Datalogic announces the release of the Matrix 210N™, an ultra-compact 2D imager that integrates outstanding reading performance, industrial connectivity and superior customer ease-of-use.
We will be exhibiting at the Food & Drink Conference in the Aviva Stadium (Stand no.3) on Thursday, 16th of September. If you are attending, pop by our stand for a chat and to see our latest product offerings for the food & beverage sector.
Whether you are looking for equipment to process food, pharmaceuticals or chemicals processing equipment, packaging or filling equipment or other components - there are hundreds of exhibitors to see at this year's PPMA show.
Datalogic announces the Color P-Series, a new line of smart cameras featuring color image sensors. Now get Color detection tools and other new features that extend the outstanding functionalities of Datalogic smart cameras.
The UDI system, which will be phased in over several years, offers a number of benefits that will be more fully realised with the adoption and integration of UDIs into the health care delivery system. UDI implementation will improve patient safety, modernise device postmarket surveillance, and facilitate medical device innovation.
Over the past few months it has emerged that the original compliance deadline of January 2016 has been pushed back to 2018. Wrestling with the technical and logistical challenges of implementation, those on the production floor could be forgiven for losing sight of the bigger picture, which is the need to safeguard patients and consumers against the danger posed by illicit medicines.